Search   
MSDS  : Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, monohydrochloride, cis-(+-)-
CAS  : 101152-94-7
SYNONYMS  : * cis-(+-)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide monohydrochloride * F 2207 * Milnacipran hydrochloride * 1-Phenyl-1-(diethylaminocarbonyl)-2-(aminomethyl)cyclopropane hydrochloride
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : GZ1014010
CHEMICAL NAME : Cyclopropanecarboxamide,
2-(aminomethyl)-N,N-diethyl-1-phenyl-,
monohydrochloride, cis-(+-)-
CAS REGISTRY NUMBER : 101152-94-7
LAST UPDATED : 199706
DATA ITEMS CITED : 11
MOLECULAR FORMULA : C15-H22-N2-O.Cl-H
MOLECULAR WEIGHT : 282.85
COMPOUND DESCRIPTOR : Drug
Reproductive Effector
SYNONYMS/TRADE NAMES :
* cis-(+-)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide
monohydrochloride
* F 2207
* Milnacipran hydrochloride
* 1-Phenyl-1-(diethylaminocarbonyl)-2-(aminomethyl)cyclopropane
hydrochloride

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 213 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis
Behavioral - somnolence (general depressed activity)
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3089,1994

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 47100 ug/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis
Behavioral - somnolence (general depressed activity)
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3089,1994

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE/DURATION : 500 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis
Behavioral - somnolence (general depressed activity)
Gastrointestinal - nausea or vomiting
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3089,1994

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 910 mg/kg/13W-I
TOXIC EFFECTS :
Endocrine - changes in spleen weight
Nutritional and Gross Metabolic - weight loss or decreased weight gain
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - phosphatases
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3687,1994

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3640 mg/kg/52W-I
TOXIC EFFECTS :
Gastrointestinal - changes in structure or function of salivary glands
Liver - other changes
Kidney, Ureter, Bladder - urine volume increased
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3687,1994

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE/DURATION : 4095 mg/kg/13W-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation)
Sense Organs and Special Senses (Eye) - ptosis
Gastrointestinal - nausea or vomiting
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3109,1994

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE/DURATION : 9100 mg/kg/52W-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation)
Gastrointestinal - nausea or vomiting
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3109,1994

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 440 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
Reproductive - Effects on Newborn - delayed effects
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3171,1994

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 1650 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Effects on Newborn - sex ratio
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3171,1994

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 520 mg/kg
SEX/DURATION : female 17-20 day(s) after conception
lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - live birth index (measured after birth)
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4
per # born alive)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3197,1994

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 130 mg/kg
SEX/DURATION : multigeneration
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in
number of implants per female; total number of implants per corpora lutea)
Reproductive - Fertility - other measures of fertility
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 28,3197,1994

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one,1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-7b-alpha,9-beta,9a-alpha-trihydroxy-3-hydroxymethyl-1,1,6,8-alph a-tetramethyl-4- methoxy-,9a-acetate 9-myristate 27817-50-1
5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one,1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-7b-alpha,9-beta,9a-alpha-trihydroxy-3-hydroxymethyl-1,1,6,8-alph a-tetramethyl-4a- methoxy-,9,9a-didecanoate 54870-24-5
5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one,1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-beta,7b-alpha,9a-alpha-trihydroxy-3-(hydroxymethyl)-1,1,6,8-a lpha- tetramethyl-,9a-(2-methylcrotonate) 65700-60-9
5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one,1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-beta,7b-alpha,9a-alpha-trihydroxy-3-(hydroxymethyl)-1,1,6,8-a lpha- tetramethyl-,3-nicotinoate 9a-phenylacetate 74513-82-9
5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one,1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-beta,7b-alpha,9a-alpha-trihydroxy-3-(hydroxymethyl)-1,1,6,8-a lpha- tetramethyl-,9a-nonenoate 74486-17-2
5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one,1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-beta,7b-alpha,9a-alpha-trihydroxy-3-(hydroxymethyl)-1,1,6,8-a lpha- tetramethyl-,9a-phenylacetate 58821-98-0
5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one,1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-alpha,7b-alpha,9a-alpha-trihydroxy-3-hydroxymethyl-1,6,8-alph a-trimethyl-1- acetoxymethyl-,9a-(2-methylbut-2-enoate) 39071-30-2
5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one,1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-alpha,7b-alpha,9a-alpha-trihydroxy-3-hydroxymethyl-1,6,8-alph a-trimethyl-1,3-diacetoxymethyl-, 9a(2-methylbut-2-enoate) 39071-30-2
5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one,1,1a-beta,1b-alpha,2,3,4,4a,7a-beta,7b,8,9,9a-dodecahydro-4a-alpha,7b-beta,9-alpha,9a-beta-tetrahydroxy-3-(hydroxymethyl )-1,1,6,8-beta- tetramethyl-,9a-acetate 9-myristate 66731-42-8
4H-Cyclopropa(3,4)benz(1,2-e)oxireno(g)azulen-4-one,1,1a-alpha,1b-beta,1C-alpha,2a-alpha,3,3a,6a-alpha,6b,7,8,8a-dodecahydro-3a-alpha,6b-alpha,8-beta,8a-alpha-tetrah ydroxy-2a-(hydroxymethyl)-1,1,5,7-alpha-tetramethyl-,8a-acetate 8-myristate 56103-54-9
Cyclohexylamine, sulfate (11) 19834-02-7
4H-Cyclopropa(3,4)benz(1,2-e)oxireno(g)azulen-4-one,1,1a-alpha,1b-beta,1c-beta,2a-beta,3,3a,6a-alpha,6b,7,8,8a-dodecahydro-3a-alpha,6b-alpha,8-beta,8a-alpha-tetrah ydroxy-2a-(hydroxymethyl)-1,1,5,7-alpha-tetramethyl-,8a-acetate 8-myristate 76095-17-5
3'H-Cyclopropa(16,17)-D-homoandrost-16-en-3-one,16,17-dihydro-17a-hydroxy-17a-methyl-,(5-alpha,16-beta,17-beta,17a-beta)- 83606-93-3
Cyclopropanamine, 2-(2,5-dimethoxy-4-methylphenyl)-,hydrochloride, trans- 53581-71-8
Cyclopropanamine, 2-(2,4,5-trimethoxyphenyl)-,hydrochloride, trans- 53581-70-7
2H-Cyclopropa(6,7)naphtho(2,1-b)thiophene-7-carboxylic acid, 1,5,6a,7,7a,8b-hexahydro-6,8-dihydroxy-4-methyl-, ethyl ester, 3,3-dioxide 130598-00-4
Cyclopropane 75-19-4
Cyclopropaneacetic acid,alpha-(2-aminoacetamido)-alpha-methyl-, ethyl ester,hydrochloride 75-19-4
Cyclopropaneacetic acid, alpha-amino-1-methyl-, (S)- 78213-60-2
Cyclopropaneacetic acid, alpha-amino-alpha-methyl- 78213-60-2
Cyclopropaneacetic acid, alpha-amino-alpha-phenyl-,DL- 73825-76-0
Cyclohexylamine, 2-(p-tolyloxy)-, hydrochloride,trans- 73825-76-0
Cyclopropaneacrylic acid,3-carboxy-alpha,2,2-trimethyl-, 1-methyl ester, esterwith 4-hydroxy-3-methyl-2-(2,4-pentadienyl)-2-cyclopenten-1-one 121-29-9
Cyclopropanecarbamic acid, N-benzyl-, ethyl ester 2521-01-9
Cyclopropanecarbonitrile,2-benzoyl-1-(p-nitrophenyl)-3-phenyl- 2521-01-9
Cyclopropanecarbonyl chloride,2,2-dimethyl-3-(2-methylpropenyl)- 14297-81-5
Cyclopropanecarbonyl chloride, 2-phenyl-, (E)- 939-87-7
Cyclopropanecarbothioic acid, 1-phenyl-,S-(2-(diethylamino)ethyl) ester, hydrochloride 67239-15-0
Cyclopropanecarboxaldehyde, oxime 66291-30-3
Cyclopropanecarboxamide, N-acetyl- 10528-55-9
Cyclopropanecarboxamide,2-((acetylamino)methyl)-N,N-diethyl-1-phenyl-, cis- 105310-24-5
Cyclopropanecarboxamide,N-(4-acetyl-1-(2-phenylethyl)-4-piperidinyl)-N-phenyl- 60644-98-6
Cyclohexylamine, 2,2,2-trifluoroethylidene- 31185-49-6
Cyclopropanecarboxamide,N-(4-amino-3,5-dichlorophenyl)- 31185-49-6
Cyclopropanecarboxamide,2-(aminomethyl)-1-(m-chlorophenyl)-N,N-diethyl-,(Z)-, monohydrochloride 105310-37-0
Cyclopropanecarboxamide,2-(aminomethyl)-1-(o-chlorophenyl)-N,N-diethyl-,(Z)-, hydrochloride 105310-36-9
Cyclopropanecarboxamide,2-(aminomethyl)-1-(p-chlorophenyl)-N,N-diethyl-,(Z)-, monohydrochloride 105310-38-1
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-dibutyl-1-phenyl-, (Z)-, oxalate 105310-43-8
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-(p-fluorophenyl)-,(Z)-, monohydrochloride 105335-54-4
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-(p-methylphenyl)-,(Z)-, monohydrochloride 105310-39-2
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-, (E)-,monohydrochloride 105310-47-2
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-, (Z)-,monohydrochloride 86181-08-0
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,monohydrochloride, cis-(+-)- 101152-94-7
Cyclohexylamine, 1,2,2-trimethyl-, hydrochloride 91391-68-3
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-dihexyl-1-phenyl-, cis-,ethanedioate (1:1) 105310-96-1
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-dimethyl-1-phenyl-, (Z)-,monohydrochloride 105335-53-3
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-dipropyl-1-phenyl-, (Z)-, oxalate 105310-41-6
Cyclopropanecarboxamide,2-(aminomethyl)-N-ethyl-1-phenyl-, (Z)-, oxalate 105310-35-8
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-(1-methylethyl)-1-phenyl-, (Z)-,monohydrochloride 105310-42-7
Cyclopropanecarboxamide, 2-(aminomethyl)-1-phenyl-,monohydrochloride, cis- 105310-34-7

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net